Anders Vinther Olsen1, Jens Stephansen2, Eileen Leary3, Paul E Peppard4, Hong Sheungshul5, Poul Jørgen Jennum6, Helge Sorensen7, Emmanuel Mignot3. 1. Center for Sleep Sciences and Medicine, Stanford School of Medicine, Palo Alto, CA, USA; Department of Electrical Engineering, Technical University of Denmark, Kongens Lyngby, Denmark. Electronic address: Avo.blunt@gmail.com. 2. Center for Sleep Sciences and Medicine, Stanford School of Medicine, Palo Alto, CA, USA; Department of Electrical Engineering, Technical University of Denmark, Kongens Lyngby, Denmark. 3. Center for Sleep Sciences and Medicine, Stanford School of Medicine, Palo Alto, CA, USA. 4. Department of Preventive medicine, U Madison Wisconsin Madison, Wisconsin, USA. 5. Sleep Disorder Center, Catholic University, Seoul, South Korea. 6. Danish Center for Sleep Medicine, Department of Clinical Neurophysiology, Rigshospitalet, Denmark. 7. Department of Electrical Engineering, Technical University of Denmark, Kongens Lyngby, Denmark.
Abstract
BACKGROUND: Type 1 narcolepsy (NT1) is characterized by symptoms believed to represent Rapid Eye Movement (REM) sleep stage dissociations, occurrences where features of wake and REM sleep are intermingled, resulting in a mixed state. We hypothesized that sleep stage dissociations can be objectively detected through the analysis of nocturnal Polysomnography (PSG) data, and that those affecting REM sleep can be used as a diagnostic feature for narcolepsy. NEW METHOD: A Linear Discriminant Analysis (LDA) model using 38 features extracted from EOG, EMG and EEG was used in control subjects to select features differentiating wake, stage N1, N2, N3 and REM sleep. Sleep stage differentiation was next represented in a 2D projection. Features characteristic of sleep stage differences were estimated from the residual sleep stage probability in the 2D space. Using this model we evaluated PSG data from NT1 and non-narcoleptic subjects. An LDA classifier was used to determine the best separation plane. COMPARISON WITH EXISTING METHODS: This method replicates the specificity/sensitivity from the training set to the validation set better than many other methods. RESULTS: Eight prominent features could differentiate narcolepsy and controls in the validation dataset. Using a composite measure and a specificity cut off 95% in the training dataset, sensitivity was 43%. Specificity/sensitivity was 94%/38% in the validation set. Using hypersomnia subjects, specificity/sensitivity was 84%/15%. Analyzing treated narcoleptics the specificity/sensitivity was 94%/10%. CONCLUSION: Sleep stage dissociation can be used for the diagnosis of narcolepsy. However the use of some medications and presence of undiagnosed hypersomnolence patients impacts the result.
BACKGROUND: Type 1 narcolepsy (NT1) is characterized by symptoms believed to represent Rapid Eye Movement (REM) sleep stage dissociations, occurrences where features of wake and REM sleep are intermingled, resulting in a mixed state. We hypothesized that sleep stage dissociations can be objectively detected through the analysis of nocturnal Polysomnography (PSG) data, and that those affecting REM sleep can be used as a diagnostic feature for narcolepsy. NEW METHOD: A Linear Discriminant Analysis (LDA) model using 38 features extracted from EOG, EMG and EEG was used in control subjects to select features differentiating wake, stage N1, N2, N3 and REM sleep. Sleep stage differentiation was next represented in a 2D projection. Features characteristic of sleep stage differences were estimated from the residual sleep stage probability in the 2D space. Using this model we evaluated PSG data from NT1 and non-narcoleptic subjects. An LDA classifier was used to determine the best separation plane. COMPARISON WITH EXISTING METHODS: This method replicates the specificity/sensitivity from the training set to the validation set better than many other methods. RESULTS: Eight prominent features could differentiate narcolepsy and controls in the validation dataset. Using a composite measure and a specificity cut off 95% in the training dataset, sensitivity was 43%. Specificity/sensitivity was 94%/38% in the validation set. Using hypersomnia subjects, specificity/sensitivity was 84%/15%. Analyzing treated narcoleptics the specificity/sensitivity was 94%/10%. CONCLUSION: Sleep stage dissociation can be used for the diagnosis of narcolepsy. However the use of some medications and presence of undiagnosed hypersomnolence patients impacts the result.
Authors: Cathy A Goldstein; Richard B Berry; David T Kent; David A Kristo; Azizi A Seixas; Susan Redline; M Brandon Westover Journal: J Clin Sleep Med Date: 2020-04-15 Impact factor: 4.062
Authors: Diane C Lim; Diego R Mazzotti; Kate Sutherland; Jesse W Mindel; Jinyoung Kim; Peter A Cistulli; Ulysses J Magalang; Allan I Pack; Philip de Chazal; Thomas Penzel Journal: Sleep Med Rev Date: 2020-03-20 Impact factor: 11.609
Authors: Lois E Krahn; Donna L Arand; Alon Y Avidan; David G Davila; William A DeBassio; Chad M Ruoff; Christopher G Harrod Journal: J Clin Sleep Med Date: 2021-12-01 Impact factor: 4.324
Authors: Jens B Stephansen; Alexander N Olesen; Mads Olsen; Aditya Ambati; Eileen B Leary; Hyatt E Moore; Oscar Carrillo; Ling Lin; Fang Han; Han Yan; Yun L Sun; Yves Dauvilliers; Sabine Scholz; Lucie Barateau; Birgit Hogl; Ambra Stefani; Seung Chul Hong; Tae Won Kim; Fabio Pizza; Giuseppe Plazzi; Stefano Vandi; Elena Antelmi; Dimitri Perrin; Samuel T Kuna; Paula K Schweitzer; Clete Kushida; Paul E Peppard; Helge B D Sorensen; Poul Jennum; Emmanuel Mignot Journal: Nat Commun Date: 2018-12-06 Impact factor: 14.919
Authors: Christopher Wood; Matt Travis Bianchi; Chang-Ho Yun; Chol Shin; Robert Joseph Thomas Journal: Front Physiol Date: 2020-12-03 Impact factor: 4.566